Who owns Atyr Pharma Inc?
- Ticker: ATYR
- CUSIP Number: 002120202
Tip: Access positions for across all investors
Analyze quarterly positions in Atyr Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atyr Pharma stock
Who bought or sold Atyr Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 15M | $53M | 0% | Dec 2024 |
|
| FMR | 12M | $44M | 6% | Dec 2024 |
|
| Point72 Asset Management | 4.9M | $18M | 100% | Dec 2024 |
|
| Vanguard Group | 3.6M | $13M | 21% | Dec 2024 |
|
| Tikvah Management | 2.5M | $8.9M | 0% | Dec 2024 |
|
| Checkpoint Capital | 1.7M | $3.1M | -11% | Sep 2024 |
|
| Woodline Partners | 1.7M | $6.1M | 0% | Dec 2024 |
|
| BlackRock | 1.5M | $5.5M | 9% | Dec 2024 |
|
| Alyeska Investment Group | 1.3M | $4.6M | -26% | Dec 2024 |
|
| Adage Capital Partners GP | 1.0M | $3.6M | 0% | Dec 2024 |
|
| Logos Global Management | 1.0M | $3.6M | -50% | Dec 2024 |
|
| Octagon Capital Advisors | 900k | $3.3M | 100% | Dec 2024 |
|
| Geode Capital Management | 891k | $3.2M | 10% | Dec 2024 |
|
| Susquehanna International | 822k | $3.0M | 456% | Dec 2024 |
|
| Ghost Tree Capital | 800k | $1.4M | 0% | Sep 2024 |
|
| Tang Capital Management | 671k | $2.4M | 0% | Dec 2024 |
|
| Renaissance Technologies | 575k | $2.1M | -50% | Dec 2024 |
|
| Qube Research & Technologies | 430k | $1.6M | 209% | Dec 2024 |
|
| Integral Health Asset Management | 375k | $1.4M | 100% | Dec 2024 |
|
| Millennium Management | 368k | $1.3M | 239% | Dec 2024 |
|
| State Street Corporation | 301k | $1.1M | 79% | Dec 2024 |
|
| J. Goldman & Co | 300k | $1.1M | 100% | Dec 2024 |
|
| GSA Capital Partners | 274k | $993k | -4% | Dec 2024 |
|
| Goldman Sachs Group | 262k | $948k | 100% | Dec 2024 |
|
| 683 Capital Management | 248k | $898k | 100% | Dec 2024 |
|
| Dimensional Fund Advisors | 243k | $881k | 67% | Dec 2024 |
|
| Royal Bank of Canada | 239k | $865k | 101% | Dec 2024 |
|
| UBS Group | 230k | $831k | 100% | Dec 2024 |
|
| Jane Street | 199k | $720k | 738% | Dec 2024 |
|
| Northern Trust | 183k | $661k | 40% | Dec 2024 |
|
| Jpmorgan Chase & Co | 179k | $646k | 468% | Dec 2024 |
|
| Barclays | 159k | $577k | 100% | Dec 2024 |
|
| OMERS Administration Corporation | 138k | $500k | 100% | Dec 2024 |
|
| Knott David M Jr | 107k | $189k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 106k | $383k | 4131% | Dec 2024 |
|
| Citigroup | 105k | $378k | -21% | Dec 2024 |
|
| Bank of America Corporation | 91k | $330k | 14614% | Dec 2024 |
|
| American Century Companies | 88k | $319k | 43% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 64k | $230k | -84% | Dec 2024 |
|
| Citadel Advisors | 56k | $204k | -94% | Dec 2024 |
|
| Leucadia National Corporation | 56k | $201k | 0% | Dec 2024 |
|
| Kingswood Wealth Advisors | 47k | $170k | 100% | Dec 2024 |
|
| Balyasny Asset Management | 44k | $160k | 100% | Dec 2024 |
|
| Morgan Stanley | 41k | $149k | 4121200% | Dec 2024 |
|
| Charles Schwab Investment Management | 40k | $144k | 49% | Dec 2024 |
|
| D.A. Davidson & Co. | 39k | $141k | 34% | Dec 2024 |
|
| Tower Research Capital | 33k | $119k | 143% | Dec 2024 |
|
| Wolverine Trading | 32k | $113k | 100% | Dec 2024 |
|
| Oxford Asset Management | 32k | $115k | 100% | Dec 2024 |
|
| Diametric Capital | 30k | $108k | 100% | Dec 2024 |
|
| Squarepoint Ops | 27k | $96k | 99% | Dec 2024 |
|
| Farther Finance Advisors | 24k | $88k | -27% | Dec 2024 |
|
| Two Sigma Investments | 22k | $78k | 100% | Dec 2024 |
|
| Occudo Quantitative Strategies | 21k | $37k | 100% | Sep 2024 |
|
| Alpine Partners VI | 17k | $63k | 100% | Dec 2024 |
|
| ExodusPoint Capital Management | 17k | $61k | 100% | Dec 2024 |
|
| Man Group | 15k | $55k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 15k | $53k | 100% | Dec 2024 |
|
| Simplex Trading | 13k | $47k | 1566% | Dec 2024 |
|
| Two Sigma Advisers | 12k | $44k | -84% | Dec 2024 |
|
| XTX Topco | 11k | $41k | -35% | Dec 2024 |
|
| Raymond James Financial | 11k | $39k | 100% | Dec 2024 |
|
| Victory Capital Management | 10k | $37k | 100% | Dec 2024 |
|
| Springbok Capital Management | 10k | $37k | 100% | Dec 2024 |
|
| Actinver Wealth Management | 10k | $36k | 0% | Dec 2024 |
|
| Group One Trading | 7.2k | $26k | 100% | Dec 2024 |
|
| BFSG | 2.0k | $7.2k | 100% | Dec 2024 |
|
| Point72 Asia | 1.2k | $4.5k | 100% | Dec 2024 |
|
| Sachetta | 400.00 | $1.4k | 167% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 358.00 | $630.008400 | 100% | Sep 2024 |
|
| PFS Partners | 340.00 | $1.2k | 0% | Dec 2024 |
|
| MAI Wealth Advisors | 215.00 | $779.009500 | 100% | Dec 2024 |
|
| Continuum Advisory | 210.00 | $759.990000 | 0% | Dec 2024 |
|
| Caldwell Sutter Capital | 52.00 | $188.000800 | 0% | Dec 2024 |
|
| Strategic Investment Solutions | 8.00 | $29.000000 | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.00 | $7.000000 | 100% | Dec 2024 |
|
Who sold out of Atyr Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Superstring Capital Management | Jun 2024 | 313k | $488k |
| Main Street Financial Solutions | Sep 2024 | 67k | $117k |
| Virtu Financial | Sep 2024 | 29k | $51k |
| Engineers Gate Manager | Sep 2024 | 16k | $28k |
| Marshall Wace | Sep 2024 | 14k | $25k |
| Two Sigma Securities | Sep 2024 | 13k | $23k |
| Ground Swell Capital | Sep 2024 | 13k | $22k |